Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia

Leukemia Research

Volumn 37, Issue 8, 2013, Pages 928-935

  La Starza, Roberta ^a   Lettieri, Antonella ^b   Pierini, Valentina ^a   Nofrini, Valeria ^a   Gorello, Paolo ^a   Songia, Simona ^b   Crescenzi, Barbara ^a   te Kronnie, Geertruy ^c   Giordan, Marco ^c   Leszl, Anna ^c   Valsecchi, Maria Grazia ^b   Aversa, Franco ^d,e   Basso, Giuseppe ^c   Biondi, Andrea ^b   Conter, Valentino ^b   Cazzaniga, Giovanni ^b   Mecucci, Cristina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d Pediatric Onco Hematology   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

Author keywords

CI FISH; Driving molecular lesions; GEP; Paediatric T ALL; Secondary events; SNP

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER PROGNOSIS; CHILD; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; COMBINED INTERPHASE FLUORESCENCE IN SITU HYBRIDIZATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE EXPRESSION PROFILING; GENETIC DISORDER; GENETIC LINKAGE; HOXA GENE; HUMAN; LMO GENE; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MOLECULAR DIAGNOSIS; NKX2 1 GENE; PATIENT CODING; PERSONALIZED MEDICINE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL LEUKEMIA; TAL GENE; TLX1 GENE; TLX3 GENE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPE; MALE; NEOPLASM, RESIDUAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84879784602     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.04.005     Document Type: Article

References (32)

1. Van Vlierberghe P., Pieters R., Beverloo H.B., Meijerink J.P.P. Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia. Br J Haematol 2008, 143:153-168.
2. Meijerink J.P.P. Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukemia. Best Pract Res Clin Haematol 2010, 23:307-318.
3. Homminga I., Pieters R., Langerak A.W., de Rooi J.J., Stubbs A., Verstegen M., et al. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell 2011, 19:484-497.
4. Gorello P., La Starza R., Varasano E., Chiaretti S., Elia L., Pierini V., et al. Combined interphase fluorescence in situ hybridization elucidates T-cell acute lymphoblastic leukemia genetic heterogeneity in adults. Haematology 2010, 95:79-86.
5. Bungaro S., Dell'Orto M.C., Zangrando A., Basso D., Gorletta T., Lo Nigro L., et al. Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks. Genes Chromosomes Cancer 2009, 48:22-38.
6. Mullighan C.G., Downing J.R. Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. Leukemia 2009, 23:1209-1218.
7. Ferrando A.A., Neuberg D.S., Staunton J., Loh M.L., Huard C., Raimondi S.C., et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002, 1:75-87.
8. Soulier J., Clappier E., Cayuela J.M., Regnault A., García-Peydró M., Dombret H., et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 2005, 106:274-286.
9. Clappier E., Cuccuini W., Kalota A., Crinquette A., Cayuela J.M., Dik W.A., et al. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood 2007, 110:1251-1261.
10. Schrappe M., Valsecchi M.G., Bartram C.R., Schrauder A., Panzer-Grumayer R., Moricke A., et al. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL2000 study. Blood 2011, 118:2077-2084.
11. Meyer L.H., Eckhoff S.M., Queudeville M., Kraus J.M., Giordan M., Stursberg J., et al. Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways. Cancer Cell 2011, 19:206-217.
12. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
13. Tibshirani R., Hastie T., Narasimhan B., Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. PNAS 2002, 99:6567-6572.
14. Van Dongen J.J., Langerak A.W., Bruggermann M., Evans P.A., Hummel M., Lavender F.L., et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003, 17:2257-2317.
15. Van der Velden V.H., Cazzaniga G., Schrauder A., Flohr T., Sutton R., Cave H., et al. Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia 2007, 21:604-611.
16. Van Vlierberghe P., van Grotel M., Beverloo H.B., Lee C., Helgason T., Buijs-Gladdines J., et al. The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood 2006, 108:3520-3529.
17. Graux C., Cools J., Michaux L., Vandenberghe P., Hagemeijer A. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast. Leukemia 2006, 20:1496-1510.
18. Sulong S., Moorman A.V., Irving J.A., Strefford J.C., Konn Z.J., Case M.C., et al. A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. Blood 2009, 113:100-107.
19. De Keersmaecker K., Real P.J., Gatta G.D., Palomero T., Sulis M.L., Tosello V., et al. The TLX1 oncogene drives aneuploidy in T cell transformation. Nat Med 2010, 16:1321-1327.
20. Schneider N.R., Carroll A.J., Shuster J.J., Pullen D.J., Link M.P., Borowitz M.J., et al. New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Blood 2000, 96:2543-2549.
21. Ballerini P., Blaise A., Busson-Le Coniat M., Su X.Y., Zucman-Rossi J., Adam M., et al. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with a poor prognosis. Blood 2002, 100:991-997.
22. Kees U.R., Heerema N.A., Kumar R., Watt P.M., Baker D.L., La M.K., et al. Sather HN expression of HOX11 in childhood T-lineage acute lymphoblastic leukemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG). Leukemia 2003, 17:887-893.
23. Cave H., Suciu S., Preudhomme C., Poppe B., Robert A., Uyttebroeck A., et al. EORTC-CLG. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL1 fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood 2004, 103:442-450.
24. Ferrando A.A., Neuberg D.S., Dodge R.K., Paietta E., Larson R.A., Wiernik P.H., et al. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukemia. Lancet 2004, 363:535-536.
25. van Grotel M., Meijerink J.P., Beverloo H.B., Langerak A.W., Buys-Gladdines J.G., Schneider P., et al. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. Haematology 2006, 91:1212-1221.
26. Baak U., Gokbuget N., Orawa H., Schartz S., Hoelzer D., Thiel E., et al. A German Multicenter ALL Study Group. Thymic adult T-cell acute lymphoblastic leukemia stratified in standard and high- risk group by aberrant HOX11L2 expression: experience of the German multicenter ALL study group. Leukemia 2008, 22:1154-1160.
27. Hagemeijer A., Graux C. ABL1 rearrangements in T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 2010, 49:299-308.
28. Gutierrez A., Sanda T., Grebliunaite R., Carracedo A., Salmena L., Ahn Y., et al. High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastica leukemia. Blood 2009, 114:647-650.
29. Remke M., Pfister S., Kox C., Toedt G., Becker N., Benner A., et al. High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. Blood 2009, 114:1053-1062.
30. Ehrhardt H., Wachter F., Maurer M., Stahnke K., Jeremias I. Important role of caspase-8 for chemo-sensitivity of ALL cells. Clin Cancer Res 2010, 17:7605-7613.
31. Yang-Li Y.L., Lin S.R., Chen J.S., Lin S.W., Yu S.L., Chen H.Y., et al. Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia. Leuk Res 2010, 34:18-23.
32. Bene M.C., Castoldi G., Knapp W., Ludwig W.D., Matutes E., Orfao A., et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995, 9:1783-1786.